3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Genitourinary
2
Other hematologic neoplasm
1
CNS
1
Breast
1
Conditions
Sleep Initiation and Maintenance Disorders
1
Oligodendroglioma
1
Meningioma
1
Lymphoma
1
Glioma
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
258
Radiotherapy
147
Bevacizumab
142
Etoposide
68
Cyclophosphamide
68
Carboplatin
66
Magnetic Resonance Spectroscopy
58
Irinotecan
53
Cisplatin
52
Vincristine
45
Filgrastim
43
pembrolizumab
40
Radiosurgery
36
Nivolumab
36
Radiation
34
Topotecan
31
Doxorubicin
30
Specimen Handling
29
sargramostim
28
Lomustine
27
Erlotinib Hydrochloride
27
Peripheral Blood Stem Cell Transplantation
25
Carmustine
25
Thiotepa
24
Everolimus
23
Chemotherapy, Adjuvant
23
Surgical Procedures, Operative
22
Isotretinoin
22
Ipilimumab
22
Melphalan
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cognitive Behavioral Therapy
×
CNS
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled